Bank of New York Mellon’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8M | Buy |
849,718
+68,921
| +9% | +$618K | ﹤0.01% | 2146 |
|
|
2026
Q1 | $6.36M | Sell |
780,797
-15,522
| -2% | -$141K | ﹤0.01% | 2185 |
|
|
2025
Q4 | $5.35M | Buy |
796,319
+307,074
| +63% | +$2.31M | ﹤0.01% | 2284 |
|
|
2025
Q3 | $4.24M | Buy |
489,245
+15,347
| +3% | +$119K | ﹤0.01% | 2417 |
|
|
2025
Q2 | $2.99M | Buy |
473,898
+19,466
| +4% | +$129K | ﹤0.01% | 2551 |
|
|
2025
Q1 | $2.91M | Buy |
454,432
+17,981
| +4% | +$149K | ﹤0.01% | 2495 |
|
|
2024
Q4 | $3.51M | Buy |
436,451
+1,664
| +0.4% | +$16K | ﹤0.01% | 2481 |
|
|
2024
Q3 | $5.49M | Sell |
434,787
-99,155
| -19% | -$1.28M | ﹤0.01% | 2248 |
|
|
2024
Q2 | $6.76M | Buy |
533,942
+136,472
| +34% | +$1.37M | ﹤0.01% | 2168 |
|
|
2024
Q1 | $1.9M | Buy |
397,470
+5,032
| +1% | +$23.3K | ﹤0.01% | 2788 |
|
|
2023
Q4 | $1.88M | Buy |
392,438
+27,906
| +8% | +$171K | ﹤0.01% | 2862 |
|
|
2023
Q3 | $2.64M | Buy |
364,532
+13,326
| +4% | +$106K | ﹤0.01% | 2653 |
|
|
2023
Q2 | $2.61M | Buy |
351,206
+108,392
| +45% | +$852K | ﹤0.01% | 2679 |
|
|
2023
Q1 | $1.68M | Sell |
242,814
-27,862
| -10% | -$256K | ﹤0.01% | 2894 |
|
|
2022
Q4 | $2.78M | Sell |
270,676
-43,012
| -14% | -$759K | ﹤0.01% | 2667 |
|
|
2022
Q3 | $5.71M | Buy |
313,688
+6,628
| +2% | +$287K | ﹤0.01% | 2227 |
|
|
2022
Q2 | $15.8M | Buy |
307,060
+18,838
| +7% | +$976K | ﹤0.01% | 1674 |
|
|
2022
Q1 | $21.2M | Sell |
288,222
-2,414
| -0.8% | -$215K | ﹤0.01% | 1641 |
|
|
2021
Q4 | $41.6M | Buy |
290,636
+1,970
| +0.7% | +$338K | 0.01% | 1283 |
|
|
2021
Q3 | $59.8M | Buy |
288,666
+17,852
| +7% | +$3.93M | 0.01% | 1020 |
|
|
2021
Q2 | $57.5M | Sell |
270,814
-5,148
| -2% | -$943K | 0.01% | 1048 |
|
|
2021
Q1 | $50M | Sell |
275,962
-23,913
| -8% | -$4.77M | 0.01% | 1113 |
|
|
2020
Q4 | $33.4M | Buy |
299,875
+17,052
| +6% | +$1.81M | 0.01% | 1305 |
|
|
2020
Q3 | $30.6M | Sell |
282,823
-11,661
| -4% | -$1.42M | 0.01% | 1192 |
|
|
2020
Q2 | $24.5M | Buy |
294,484
+129,940
| +79% | +$4.97M | 0.01% | 1318 |
|
|
2020
Q1 | $2.23M | Buy |
164,544
+35,693
| +28% | +$302K | ﹤0.01% | 2493 |
|
|
2019
Q4 | $513K | Sell |
128,851
-4,229
| -3% | -$18.3K | ﹤0.01% | 3583 |
|
|
2019
Q3 | $668K | Buy |
133,080
+30,501
| +30% | +$167K | ﹤0.01% | 3386 |
|
|
2019
Q2 | $601K | Buy |
102,579
+14,593
| +17% | +$115K | ﹤0.01% | 3511 |
|
|
2019
Q1 | $969K | Sell |
87,986
-2,665
| -3% | -$84.1K | ﹤0.01% | 3208 |
|
|
2018
Q4 | $3.34M | Buy |
90,651
+10
| +0% | +$388 | ﹤0.01% | 2493 |
|
|
2018
Q3 | $3.41M | Buy |
90,641
+4,599
| +5% | +$130K | ﹤0.01% | 2574 |
|
|
2018
Q2 | $2.31M | Buy |
86,042
+10,062
| +13% | +$340K | ﹤0.01% | 2777 |
|
|
2018
Q1 | $3.19M | Buy |
75,980
+6,387
| +9% | +$257K | ﹤0.01% | 2563 |
|
|
2017
Q4 | $1.73M | Buy |
69,593
+1,711
| +3% | +$41.7K | ﹤0.01% | 2929 |
|
|
2017
Q3 | $1.55M | Sell |
67,882
-1,699
| -2% | -$38K | ﹤0.01% | 2980 |
|
|
2017
Q2 | $1.6M | Buy |
69,581
+8,826
| +15% | +$173K | ﹤0.01% | 2977 |
|
|
2017
Q1 | $1.55M | Buy |
60,755
+517
| +0.9% | +$14.2K | ﹤0.01% | 3005 |
|
|
2016
Q4 | $1.52M | Sell |
60,238
-110
| -0.2% | -$3.21K | ﹤0.01% | 3030 |
|
|
2016
Q3 | $2.51M | Sell |
60,348
-1,176
| -2% | -$152K | ﹤0.01% | 2624 |
|
|
2016
Q2 | $8.95M | Sell |
61,524
-229
| -0.4% | -$26.2K | ﹤0.01% | 1910 |
|
|
2016
Q1 | $6.37M | Sell |
61,753
-792
| -1% | -$85K | ﹤0.01% | 2061 |
|
|
2015
Q4 | $10.5M | Sell |
62,545
-3,820
| -6% | -$588K | ﹤0.01% | 1811 |
|
|
2015
Q3 | $9.38M | Sell |
66,365
-12,122
| -15% | -$2.72M | ﹤0.01% | 1894 |
|
|
2015
Q2 | $17.5M | Buy |
78,487
+8,386
| +12% | +$1.47M | ﹤0.01% | 1571 |
|
|
2015
Q1 | $11.6M | Sell |
70,101
-140
| -0.2% | -$22.7K | ﹤0.01% | 1871 |
|
|
2014
Q4 | $8.33M | Sell |
70,241
-5
| -0% | -$523 | ﹤0.01% | 2016 |
|
|
2014
Q3 | $5.86M | Buy |
70,246
+9,963
| +17% | +$900K | ﹤0.01% | 2216 |
|
|
2014
Q2 | $5.57M | Buy |
60,283
+4,337
| +8% | +$381K | ﹤0.01% | 2269 |
|
|
2014
Q1 | $5.07M | Buy |
55,946
+1,409
| +3% | +$157K | ﹤0.01% | 2301 |
|
|
2013
Q4 | $5.58M | Buy |
54,537
+17,025
| +45% | +$1.2M | ﹤0.01% | 2231 |
|
|
2013
Q3 | $2.36M | Buy |
37,512
+4,091
| +12% | +$230K | ﹤0.01% | 2743 |
|
|
2013
Q2 | $1.37M | Buy |
+33,421
| New | +$1.45M | ﹤0.01% | 3006 |
|
Other funds holding NVAX
S
TCMG
JAM
MAM
EP
Bank of New York Mellon's NVAX Position: Q2 2026 in Review
Bank of New York Mellon increased its Novavax (NVAX) stake by 8.8% in Q2 2026, buying an estimated $618K and bringing the position to 849,718 shares worth $8M. The position accounts for ﹤0.01% of the portfolio, ranked #2146.
Bank of New York Mellon first reported a position in NVAX in Q2 2013 and has held it in 53 quarters since. The position peaked at $59.8M in Q3 2021. 150 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Bank of New York Mellon held 849,718 shares of Novavax worth $8M as of Q2 2026.
- Bank of New York Mellon bought 68,921 Novavax shares in Q2 2026, an estimated $618K.
- Novavax made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2146 holding.
- Bank of New York Mellon first reported a position in Novavax in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Novavax position peaked at $59.8M in Q3 2021.
- 150 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.